Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer
Go back to Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.94 | 52 Week High | $1.37 | |||
| Open | $0.94 | 52 Week Low | $0.24 | |||
| Day High | $0.94 | P/E | N/A | |||
| Day Low | $0.94 | EPS | $0.00 | |||
| Volume | 172 | |||||
